News & Publications
News ·
March 25, 2025
Cheng: Announcing Character Bio’s Series B
Our CEO shares his thoughts on the company's next phase
News ·
January 10, 2025
Character Bio Announces Collaboration with Bausch + Lomb
Collaboration seeks to transform ophthalmology with precision medicine
News ·
December 3, 2024
Dry-AMD Progression Study: Interim Results
Character Bio
News ·
May 3, 2024
Character Bio at ARVO 2024
Character Bio
News ·
September 13, 2023
Welcoming Dr. Laura Carter
Laura Carter, Ph.D, joins Character Bio as Chief Scientific Officer
News ·
May 17, 2022
Cheng: A patient-driven therapeutics company
Our CEO shares Character's patient-first DNA
News ·
May 17, 2022
Vivek: Character Biosciences milestone
The CEO of Clover Health details the aligned missions for Clover & Character and our progress
News ·
May 17, 2022
Cantos Ventures: Precision medicine meets drug discovery
Cantos describes why they have chosen to partner with Character through multiple rounds of financing
No results found.
There are no results with this criteria. Try changing your search.